Suggested guidelines for convalescent plasma therapy for the treatment of COVID-19

Overview of attention for article published in Hematology Transfusion and Cell Therapy, March 2021

Altmetric Badge

Mentioned by

twitter: 5 X users

Citations

dimensions_citation: 17 Dimensions

Readers on

mendeley: 35 Mendeley

Summary X Dimensions citations

So far, Dimensions has found 17 publications that cite this research output.

17

The most recent citing publications are shown below. View all 17 publications that cite this research output on Dimensions.

Comparative immunogenicity and neutralizing antibody responses post heterologous vaccination with CoronaVac (Sinovac) and Vaxzevria (AstraZeneca) in HIV-infected patients with varying CD4+ T lymphocyte counts

Article in Human Vaccines & Immunotherapeutics (January 2024)

Hybrid immunity from SARS-CoV-2 infection and mRNA BNT162b2 vaccine among Thai school-aged children

Article in Vaccine X (November 2023)

Efficacy of combined COVID-19 convalescent plasma with oral RNA-dependent RNA polymerase inhibitor treatment versus neutralizing monoclonal antibody therapy in COVID-19 outpatients: a multi-center, non-inferiority, open-label randomized controlled trial (PlasMab)

Article in Microbiology Spectrum (November 2023)

This page shows the most recent citations of this research output.

Click here to find out how to access more activity.